Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GE Healthcare
MedTech
Lantheus taps GE HealthCare to sell its PSMA PET tracer in Japan
Lantheus gave GE HealthCare the rights to its Pylarify prostate cancer imaging agent in Japan, which plans to lean on its Nihon Medi-Physics division.
Conor Hale
Sep 24, 2025 11:30am
GE HealthCare considering stake sale in China division: report
Sep 18, 2025 2:30pm
GE HealthCare to acquire brain MRI AI developer icometrix
Sep 10, 2025 11:45am
GE HealthCare's PET agent Vizamyl expands reach in Alzheimer's
Jun 27, 2025 9:45am
Tariff-driven uncertainty rattles medtech industry
Jun 3, 2025 10:40am
GE HealthCare rolls out new AI-equipped SPECT/CT scanner
May 7, 2025 9:00am